Suzanne et al. and Samuel et al. achieved similar results, finding that CD80-Fc could sustain IFN-γ production by both human and murine PD-1+ activated T cells in the presence of PD-L1+ human or mouse tumor cells, respectively. Here, CD274 is linked to neoplasm.